Searched for
3RD DOSE
Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Weight is over! Pharma stocks jump up to 4% as patent for Ozempic's key ingredient expires; what lies ahead?Pharma stocks rose up to 4% as Novo Nordisk’s semaglutide patent nears expiry, raising expectations of cheaper generics in India. Strong gr...
- Natco launches Rs 1,290 semaglutide in India, undercuts diabetes drug pricesNatco Pharma has launched a new generic semaglutide injection in India. This marks a significant step in making advanced diabetes treatment...
- Karnataka govt starts mandatory COVID tests for ILI, SARI patients, advises people to wear masks indoorsChief Minister Basvaraj Bommai on COVID management, Health Minister Dr K Sudhakar said, "In view of the increase in COVID cases in several ...
- PSU vaccine maker IIL to invest Rs 700 crore on new facility in HyderabadThe proposed facility will be making Foot and Mouth disease (FMD) and other emerging diseases. The facility will create total employment fo...
- Enhance Covid awareness activities, step up administration of 3rd dose, suggest expertsThe Ministry of Health and Family Welfare (MoHFW) has also advised that in the coming months, from September 26 to December 31, mass gather...
- Bharat Biotech seeks nod for intranasal Covid vaccineAccording to the vaccine maker, it conducted two separate and simultaneous clinical trials to evaluate its intranasal vaccine (BBV154) as a...
- Submitted data for approval of intranasal vaccine to drug regulator: Bharat BiotechAccording to the vaccine maker, it conducted two separate and simultaneous clinical trials to evaluate its intranasal vaccine (BBV154) as a...
- Current booster policy needs to be updated: ExpertsGiridhara Babu, senior epidemiologist said it is time to revise and ensure that every eligible person gets a booster shot if not got alread...
- Third vaccine dose can boost effectiveness against Omicron to 88%, UK studies showThe findings compiled in a report by the UK Health Security Agency (UKSHA) show significantly higher protection provided by third vaccine d...
- NTAGI, working group to take call on 3rd dose for IndiaNTAGI is reviewing scientific evidence and will decide whether the vaccine platform should be different for the third dose, people with kno...
- Vaccines for children aged 15-18 years: How to registerThe registration process will require the children to submit 'student id cards' on the CoWIN portal for Covid-19 vaccination, as per Sharma...
- India to begin vaccination for children aged 15 years and up, booster doses for some from JanuaryBooster doses for frontline workers, as well as co-morbid patients aged 60 years and up, will be given from January 10.
- Booster dose of six Covid vaccines safe, increases immunity: Lancet studyProtection against COVID-19 infection wanes over time, which has driven consideration of boosters to protect the most vulnerable and lessen...
- Congress alleges shortage of vaccines in states, says third COVID wave may hit India 'very badly'Rahul Gandhi, who has been persistently targeting the Centre over its handling of the pandemic, said there are "jumlas (rhetoric)" but no v...
- Eight states account for over 80 per cent of new COVID-19 casesIndia is seeing a steep intensification in the doubling time of the COVID-19 cases. As of April 4, it is 115.4 days, the ministry said on S...
- Serum Institute could earn $4 billion from vaccine sales in 2 yearsPune's Serum Institute of India, the world’s largest vaccine manufacturer, is expected to generate $4 billion in revenues through its Covid...
- With 11,831 new COVID-19 cases India's tally reaches to 1,08,38 194Continuing its streak of low numbers of single-day coronavirus cases, India reported 11,831 new infections in the last 24 hours even as its...
- India may get COVID-19 vaccine by early 2021, says Bernstein ResearchWhile the vaccine could be available at USD 3-6 (Rs 225 to Rs 550) per dose, herd immunity might be two years away due to implementation ch...
Load More
